Authors:
Colnot, DR
Wilhelm, AJ
Cloos, J
Roos, JC
de Bree, R
Quak, JJ
Snow, GB
van Dongen, GAMS
Citation: Dr. Colnot et al., Evaluation of limited blood sampling in a preceding Tc-99m-labeled diagnostic study to predict the pharmacokinetics and myelotoxicity of Re-186-cMAb U36 radioimmunotherapy, J NUCL MED, 42(9), 2001, pp. 1364-1367
Authors:
Cloos, J
Leemans, CR
van der Sterre, MLT
Kuik, DJ
Snow, GB
Braakhuis, BJM
Citation: J. Cloos et al., Mutagen sensitivity as a biomarker for second primary tumors after head and neck squamous cell carcinoma, CANC EPID B, 9(7), 2000, pp. 713-717
Citation: Kkh. Aben et al., Mutagen sensitivity in patients with familial and non-familial urothelial cell carcinoma, INT J CANC, 88(3), 2000, pp. 493-496
Authors:
Cloos, J
Nieuwenhuis, EJC
Boomsma, DI
Kuik, DJ
van der Sterre, MLT
Arwert, F
Snow, GB
Braakhuis, BJM
Citation: J. Cloos et al., Inherited susceptibility to bleomycin-induced chromatid breaks in culturedperipheral blood lymphocytes, J NAT CANC, 91(13), 1999, pp. 1125-1130
Authors:
Cloos, J
Willems, EM
van Warmerdam, JMB
Braakhuis, BJM
Snow, GB
Meijer, S
Citation: J. Cloos et al., Mutagen sensitivity in common cutaneous malignant melanoma and dysplastic naevus syndrome, MELANOMA RE, 9(3), 1999, pp. 292-296
Citation: Bjm. Braakhuis et al., Effect of cisplatin exposure on platinum accumulation and growth inhibition in human neoplastic and normal squamous epithelial cells of the mucosa ofthe upper-aerodigestive tract, CANCER LETT, 138(1-2), 1999, pp. 217-220
Authors:
Cloos, J
Reid, CBA
van der Sterre, MLT
Tobi, H
Leemans, CR
Snow, GB
Braakhuis, BJM
Citation: J. Cloos et al., A comparison of bleomycin-induced damage in lymphocytes and primary oral fibroblasts and keratinocytes in 30 subjects, MUTAGENESIS, 14(1), 1999, pp. 87-93